UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A tool with many applications: vesicular stomatitis virus in research and medicine

Munis, AM; Bentley, EM; Takeuchi, Y; (2020) A tool with many applications: vesicular stomatitis virus in research and medicine. Expert Opinion on Biological Therapy 10.1080/14712598.2020.1787981. (In press). Green open access

[thumbnail of 10_08_2020_A tool wit.pdf]
Preview
Text
10_08_2020_A tool wit.pdf - Published Version

Download (3MB) | Preview

Abstract

INTRODUCTION: Vesicular stomatitis virus (VSV) has long been a useful research tool in virology and recently become an essential part of medicinal products. Vesiculovirus research is growing quickly following its adaptation to clinical gene and cell therapy and oncolytic virotherapy. AREAS COVERED: This article reviews the versatility of VSV as a research tool and biological reagent, its use as a viral and vaccine vector delivering therapeutic and immunogenic transgenes and an oncolytic virus aiding cancer treatment. Challenges such as the immune response against such advanced therapeutic medicinal products and manufacturing constraints are also discussed. EXPERT OPINION: The field of in vivo gene and cell therapy is advancing rapidly with VSV used in many ways. Comparison of VSV’s use as a versatile therapeutic reagent unveils further prospects and problems for each application. Overcoming immunological challenges to aid repeated administration of viral vectors and minimizing harmful host–vector interactions remains one of the major challenges. In the future, exploitation of reverse genetic tools may assist the creation of recombinant viral variants that have improved onco-selectivity and more efficient vaccine vector activity. This will add to the preferential features of VSV as an excellent advanced therapy medicinal product (ATMP) platform.

Type: Article
Title: A tool with many applications: vesicular stomatitis virus in research and medicine
Open access status: An open access version is available from UCL Discovery
DOI: 10.1080/14712598.2020.1787981
Publisher version: https://doi.org/10.1080/14712598.2020.1787981
Language: English
Additional information: © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Gene therapy, immune response, lentivirus, oncolytic virotherapy, pseudotype, vaccine, viral vector, VSV
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/10107456
Downloads since deposit
126Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item